Annual CFO
-$10.83 M
+$17.51 M+61.79%
December 31, 2023
Summary
- As of February 10, 2025, HUGE annual cash flow from operations is -$10.83 million, with the most recent change of +$17.51 million (+61.79%) on December 31, 2023.
- During the last 3 years, HUGE annual CFO has risen by +$8.30 million (+43.40%).
Performance
HUGE Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFO
-$606.48 K
+$1.37 M+69.27%
June 30, 2024
Summary
- As of February 10, 2025, HUGE quarterly cash flow from operations is -$606.48 thousand, with the most recent change of +$1.37 million (+69.27%) on June 30, 2024.
- Over the past year, HUGE quarterly CFO has increased by +$2.90 million (+82.72%).
Performance
HUGE Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFO
-$5.14 M
+$2.90 M+36.07%
June 30, 2024
Summary
- As of February 10, 2025, HUGE TTM cash flow from operations is -$5.14 million, with the most recent change of +$2.90 million (+36.07%) on June 30, 2024.
- Over the past year, HUGE TTM CFO has increased by +$16.96 million (+76.73%).
Performance
HUGE TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
HUGE Cash From Operations Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +61.8% | +82.7% | +76.7% |
| 3 y3 years | +43.4% | +90.8% | +76.6% |
| 5 y5 years | +20.2% | +89.3% | +62.5% |
HUGE Cash From Operations Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +161.7% | at high | +1449.6% | at high | +450.8% |
| 5 y | 5-year | at high | +161.7% | at high | +1449.6% | at high | +450.8% |
| alltime | all time | -915.5% | +161.7% | >+9999.0% | +1449.6% | >+9999.0% | +450.8% |
FSD Pharma Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2024 | - | -$606.48 K(-69.3%) | -$5.14 M(-36.1%) |
| Mar 2024 | - | -$1.97 M(+131.7%) | -$8.05 M(-25.7%) |
| Dec 2023 | -$10.83 M(-61.8%) | -$851.70 K(-50.3%) | -$10.83 M(-33.6%) |
| Sep 2023 | - | -$1.71 M(-51.2%) | -$16.30 M(-26.3%) |
| Jun 2023 | - | -$3.51 M(-26.2%) | -$22.10 M(-21.0%) |
| Mar 2023 | - | -$4.75 M(-24.8%) | -$27.99 M(-1.2%) |
| Dec 2022 | -$28.33 M(+36.6%) | -$6.33 M(-15.8%) | -$28.33 M(+8.6%) |
| Sep 2022 | - | -$7.52 M(-20.0%) | -$26.10 M(+12.6%) |
| Jun 2022 | - | -$9.40 M(+84.5%) | -$23.17 M(+13.8%) |
| Mar 2022 | - | -$5.09 M(+24.5%) | -$20.36 M(-1.9%) |
| Dec 2021 | -$20.75 M(+8.4%) | -$4.09 M(-10.8%) | -$20.75 M(-3.2%) |
| Sep 2021 | - | -$4.59 M(-30.3%) | -$21.43 M(-2.5%) |
| Jun 2021 | - | -$6.58 M(+20.0%) | -$21.98 M(+15.0%) |
| Mar 2021 | - | -$5.48 M(+15.0%) | -$19.12 M(-0.1%) |
| Dec 2020 | -$19.13 M(+39.5%) | -$4.77 M(-7.2%) | -$19.13 M(+10.5%) |
| Sep 2020 | - | -$5.14 M(+38.2%) | -$17.31 M(+21.3%) |
| Jun 2020 | - | -$3.72 M(-32.2%) | -$14.27 M(-11.9%) |
| Mar 2020 | - | -$5.49 M(+86.2%) | -$16.21 M(+18.2%) |
| Dec 2019 | -$13.71 M | -$2.95 M(+40.2%) | -$13.71 M(+3.5%) |
| Sep 2019 | - | -$2.10 M(-62.8%) | -$13.25 M(-30.0%) |
| Jun 2019 | - | -$5.66 M(+88.6%) | -$18.95 M(+24.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$3.00 M(+20.5%) | -$15.24 M(+11.9%) |
| Dec 2018 | -$13.58 M(>+9900.0%) | -$2.49 M(-68.1%) | -$13.62 M(+22.3%) |
| Sep 2018 | - | -$7.80 M(+299.7%) | -$11.14 M(+233.2%) |
| Jun 2018 | - | -$1.95 M(+46.0%) | -$3.34 M(+139.2%) |
| Mar 2018 | - | -$1.34 M(+2660.5%) | -$1.40 M(+2186.7%) |
| Feb 2018 | - | -$48.40 K(+1208.1%) | -$61.10 K(+174.0%) |
| Dec 2017 | -$119.20 K(+464.9%) | - | - |
| Nov 2017 | - | -$3700.00(+5.7%) | -$22.30 K(+5.7%) |
| Aug 2017 | - | -$3500.00(-36.4%) | -$21.10 K(+19.9%) |
| Aug 2017 | -$21.10 K(-22.4%) | - | - |
| May 2017 | - | -$5500.00(-42.7%) | -$17.60 K(+45.5%) |
| Feb 2017 | - | -$9600.00(+284.0%) | -$12.10 K(+384.0%) |
| Nov 2016 | - | -$2500.00 | -$2500.00 |
| Aug 2016 | -$27.20 K(>+9900.0%) | - | - |
| Aug 2015 | -$100.00(-100.0%) | - | - |
| Dec 2014 | $1.33 M(-229.3%) | - | - |
| Dec 2013 | -$1.03 M(-224.9%) | - | - |
| Dec 2012 | $822.50 K(-143.9%) | - | - |
| Dec 2011 | -$1.87 M(+195.1%) | - | - |
| Dec 2010 | -$634.30 K(-246.4%) | - | - |
| Dec 2009 | $433.40 K | - | - |
FAQ
- What is FSD Pharma annual cash flow from operations?
- What is the all time high annual CFO for FSD Pharma?
- What is FSD Pharma annual CFO year-on-year change?
- What is FSD Pharma quarterly cash flow from operations?
- What is the all time high quarterly CFO for FSD Pharma?
- What is FSD Pharma quarterly CFO year-on-year change?
- What is FSD Pharma TTM cash flow from operations?
- What is the all time high TTM CFO for FSD Pharma?
- What is FSD Pharma TTM CFO year-on-year change?
What is FSD Pharma annual cash flow from operations?
The current annual CFO of HUGE is -$10.83 M
What is the all time high annual CFO for FSD Pharma?
FSD Pharma all-time high annual cash flow from operations is $1.33 M
What is FSD Pharma annual CFO year-on-year change?
Over the past year, HUGE annual cash flow from operations has changed by +$17.51 M (+61.79%)
What is FSD Pharma quarterly cash flow from operations?
The current quarterly CFO of HUGE is -$606.48 K
What is the all time high quarterly CFO for FSD Pharma?
FSD Pharma all-time high quarterly cash flow from operations is -$2500.00
What is FSD Pharma quarterly CFO year-on-year change?
Over the past year, HUGE quarterly cash flow from operations has changed by +$2.90 M (+82.72%)
What is FSD Pharma TTM cash flow from operations?
The current TTM CFO of HUGE is -$5.14 M
What is the all time high TTM CFO for FSD Pharma?
FSD Pharma all-time high TTM cash flow from operations is -$2500.00
What is FSD Pharma TTM CFO year-on-year change?
Over the past year, HUGE TTM cash flow from operations has changed by +$16.96 M (+76.73%)